FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3044386843> ?p ?o ?g. }

• W3044386843 endingPage "211" @default.
• W3044386843 startingPage "206" @default.
• W3044386843 abstract "Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is a common treatment for peritoneal surface malignancies but no standard carrier solution currently exists for the procedure. This study compared a standard low-dextrose perfusate to a higher-dextrose dialysate that has previously shown favorable impact on perioperative patient outcomes in trauma settings.A single-center retrospective study identified patients undergoing CRS/HIPEC from 2008 to 2019 with recorded dextrose concentration of administered perfusate. An institutional shift to a higher-dextrose solution was made in late 2015. Comparisons of preoperative factors, intraoperative and postoperative glucose levels, and postoperative outcomes were made using the chi-square test, Fisher's exact test, Wilcoxon rank sum test, or repeated measures analysis of variance.There were 97 patients in the study, 73 (75%) in the low-dextrose group and 24 (25%) in the high-dextrose group. There was no significant difference in peak intraoperative blood glucose levels between the 1.5% (mean 230 mg/dL) and the 2.5% group (mean 199 mg/dL, P = 0.15). Daily postoperative glucose values were also not statistically different (repeated measures analysis of variance, P = 0.18). Median length of stay was slightly lower for the high-dextrose group (10 d, interquartile range 8-15) than that for the low-dextrose group (12 d, interquartile range 9-17), but was not statistically significant (P = 0.29). Return of bowel function and resumption of diet were similar between the groups. The high-dextrose group had a lower rate of overall complications (20.8%) than the low-dextrose group (49.3%, P = 0.0143). Ninety-day mortality was equivalent between the two groups (2.7% low-dextrose, 4.2% high-dextrose, P = 1.0).Use of 2.5% dextrose-containing perfusate appears safe for CRS/HIPEC operations, does not negatively impact intraoperative or postoperative glucose levels, and may be associated with a decreased risk of complications." @default.
• W3044386843 created "2020-07-29" @default.
• W3044386843 creator A5000260916 @default.
• W3044386843 creator A5000471404 @default.
• W3044386843 creator A5011696445 @default.
• W3044386843 creator A5020911005 @default.
• W3044386843 creator A5069026924 @default.
• W3044386843 creator A5071286571 @default.
• W3044386843 creator A5071405425 @default.
• W3044386843 date "2020-12-01" @default.
• W3044386843 modified "2023-10-17" @default.
• W3044386843 title "Impact of Perfusate Glucose Concentration on Perioperative Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy" @default.
• W3044386843 cites W17791541 @default.
• W3044386843 cites W1968961107 @default.
• W3044386843 cites W1974911052 @default.
• W3044386843 cites W2004554342 @default.
• W3044386843 cites W2005524485 @default.
• W3044386843 cites W2036235321 @default.
• W3044386843 cites W2042210669 @default.
• W3044386843 cites W2088303205 @default.
• W3044386843 cites W2093268532 @default.
• W3044386843 cites W2096998881 @default.
• W3044386843 cites W2581421338 @default.
• W3044386843 cites W2771838172 @default.
• W3044386843 cites W2914468093 @default.
• W3044386843 doi "https://doi.org/10.1016/j.jss.2020.06.055" @default.
• W3044386843 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7855042" @default.
• W3044386843 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32711177" @default.
• W3044386843 hasPublicationYear "2020" @default.
• W3044386843 type Work @default.
• W3044386843 sameAs 3044386843 @default.
• W3044386843 citedByCount "1" @default.
• W3044386843 countsByYear W30443868432022 @default.
• W3044386843 crossrefType "journal-article" @default.
• W3044386843 hasAuthorship W3044386843A5000260916 @default.
• W3044386843 hasAuthorship W3044386843A5000471404 @default.
• W3044386843 hasAuthorship W3044386843A5011696445 @default.
• W3044386843 hasAuthorship W3044386843A5020911005 @default.
• W3044386843 hasAuthorship W3044386843A5069026924 @default.
• W3044386843 hasAuthorship W3044386843A5071286571 @default.
• W3044386843 hasAuthorship W3044386843A5071405425 @default.
• W3044386843 hasBestOaLocation W30443868432 @default.
• W3044386843 hasConcept C119060515 @default.
• W3044386843 hasConcept C121608353 @default.
• W3044386843 hasConcept C126322002 @default.
• W3044386843 hasConcept C126894567 @default.
• W3044386843 hasConcept C12868164 @default.
• W3044386843 hasConcept C141071460 @default.
• W3044386843 hasConcept C191093355 @default.
• W3044386843 hasConcept C206041023 @default.
• W3044386843 hasConcept C2776694085 @default.
• W3044386843 hasConcept C2779306644 @default.
• W3044386843 hasConcept C2779412105 @default.
• W3044386843 hasConcept C2779458272 @default.
• W3044386843 hasConcept C2780427987 @default.
• W3044386843 hasConcept C2780473172 @default.
• W3044386843 hasConcept C2994223192 @default.
• W3044386843 hasConcept C31174226 @default.
• W3044386843 hasConcept C42219234 @default.
• W3044386843 hasConcept C71924100 @default.
• W3044386843 hasConcept C99476002 @default.
• W3044386843 hasConceptScore W3044386843C119060515 @default.
• W3044386843 hasConceptScore W3044386843C121608353 @default.
• W3044386843 hasConceptScore W3044386843C126322002 @default.
• W3044386843 hasConceptScore W3044386843C126894567 @default.
• W3044386843 hasConceptScore W3044386843C12868164 @default.
• W3044386843 hasConceptScore W3044386843C141071460 @default.
• W3044386843 hasConceptScore W3044386843C191093355 @default.
• W3044386843 hasConceptScore W3044386843C206041023 @default.
• W3044386843 hasConceptScore W3044386843C2776694085 @default.
• W3044386843 hasConceptScore W3044386843C2779306644 @default.
• W3044386843 hasConceptScore W3044386843C2779412105 @default.
• W3044386843 hasConceptScore W3044386843C2779458272 @default.
• W3044386843 hasConceptScore W3044386843C2780427987 @default.
• W3044386843 hasConceptScore W3044386843C2780473172 @default.
• W3044386843 hasConceptScore W3044386843C2994223192 @default.
• W3044386843 hasConceptScore W3044386843C31174226 @default.
• W3044386843 hasConceptScore W3044386843C42219234 @default.
• W3044386843 hasConceptScore W3044386843C71924100 @default.
• W3044386843 hasConceptScore W3044386843C99476002 @default.
• W3044386843 hasFunder F4320337351 @default.
• W3044386843 hasLocation W30443868431 @default.
• W3044386843 hasLocation W30443868432 @default.
• W3044386843 hasLocation W30443868433 @default.
• W3044386843 hasOpenAccess W3044386843 @default.
• W3044386843 hasPrimaryLocation W30443868431 @default.
• W3044386843 hasRelatedWork W2065286671 @default.
• W3044386843 hasRelatedWork W2067366728 @default.
• W3044386843 hasRelatedWork W2119822303 @default.
• W3044386843 hasRelatedWork W2392422383 @default.
• W3044386843 hasRelatedWork W2517704322 @default.
• W3044386843 hasRelatedWork W2581545833 @default.
• W3044386843 hasRelatedWork W2953607890 @default.
• W3044386843 hasRelatedWork W2995886480 @default.
• W3044386843 hasRelatedWork W3044386843 @default.
• W3044386843 hasRelatedWork W3141361565 @default.
• W3044386843 hasVolume "256" @default.
• W3044386843 isParatext "false" @default.

• next